hree years after Hospira tried draining the swamp, the gators are now snapping at Ian Read’s heels.

Why do we write this? That’s because Hospira manufacturing problems are plaguing Pfizer (PFE) two years after paying $15 billion for the company. At the time, Hospira was still struggling to correct quality-control issues at various plants, which caused shortages and steady rebukes from regulators. But a year before the deal, a Hospira executive declared “we’ve got the swamp drained” of gators.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.